发明名称 |
STABLE ORAL TABLET DOSAGE FORM OF AN ANTIDIABETIC COMPOUND |
摘要 |
The invention relates to a stable oral tablet dosage form comprising an antidiabetic compound (a compound of formula (I) or a pharmaceutically acceptable salt thereof) as the active pharmaceutical ingredient, a non-ionic surfactant and one or more pharmaceutically acceptable excipients. The tablet dosage form contains between 40 % w/w to 80 % w/w of the antidiabetic compound, along with a non-ionic surfactant and one or more other pharmaceutically acceptable excipients. The tablet dosage form is characterized by a specific particle size of the active pharmaceutical ingredient with immediate release pattern and increased bioavailability of the active pharmaceutical ingredient.
|
申请公布号 |
WO2013117963(A1) |
申请公布日期 |
2013.08.15 |
申请号 |
WO2012IB50579 |
申请日期 |
2012.02.09 |
申请人 |
PIRAMAL ENTERPRISES LIMITED;ENOSE, ARNO, APPAVOO |
发明人 |
ENOSE, ARNO, APPAVOO |
分类号 |
A61K9/14;A61K31/4709;A61K31/4725;A61K47/00;A61P3/10 |
主分类号 |
A61K9/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|